2024 could prove pivotal for virtual behavioral health as the federal government considers making COVID-era telehealth flexibilities permanent. Federal and state regulations can heavily influence the availability of behavioral telehealth appointments. For behavioral health providers who provide care to Medicaid beneficiaries, or who prescribe controlled substances for conditions like substance use disorders (SUDs), regulations can […]
Digital substance use disorder provider Affect Therapeutics has raised $16 million in Series A funding. ARTIS Ventures led the round with participation from AlleyCorp, CityLight, LifeArc Ventures, Samsung Next and What If Ventures. The company’s total raise comes to roughly $23 million, according to Crunchbase. Founded in 2020, Affect Therapeutics provides virtual substance use disorder […]
Contingency management has proven to be one of the most effective treatments for patients addicted to stimulants such as meth and cocaine. The practice — which rewards patients with money or prizes for hitting certain treatment milestones — has been shown to improve retention and abstinence rates. However, stigma and lack of reimbursement prevent many […]
Ellipsis raises $26M Behavioral health artificial intelligence (AI) company Ellipsis Health has scored $26 million in Series A funding. SJF Ventures led the round, with additional participation from firms such as AblePartners, Alumni Ventures, Generator Ventures, Greycroft Partners, Khosla Ventures and Luminous Ventures, among other investors. The new money brings the total amount raised by […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
